Healthcare

US limits use of Janssen vaccine to adults because of blood clot risks

by

The United States Food and Drug Administration (FDA) announced on Thursday (5) the limitation of the use of the Janssen (Johnson & Johnson) vaccine for Covid-19 in adults due to the risk of a rare syndrome. of blood clotting.

The vaccine is authorized for people over 18 and is one of three against Covid-19 released for use in the United States.

The agency said the Janssen injection may be given in cases where authorized or approved Covid-19 vaccines are not accessible or if an individual is less interested in using the other two injections.

The FDA stated that its analysis determined that the risk of thrombosis with thrombocytopenia syndrome following administration of the vaccine warrants limiting the authorization.

Johnson & Johnson did not immediately respond to a Reuters request for comment.

astrazenecoronavaccoronaviruscovid vaccinecovid-19janssenleafpandemicPfizervaccine

You May Also Like

Recommended for you